Five-factor prognostic model for survival of post-platinum patients with metastatic urothelial carcinoma receiving PD-L1 inhibitors

PURPOSE: A prognostic model for overall survival (OS) of post-platinum patients with metastatic urothelial carcinoma (mUC) receiving PD-1/PD-L1 inhibitors is necessary since existing models were constructed in the chemotherapy setting. MATERIALS AND METHODS: Patient level data were used from phase I...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Urol
Auteurs principaux: Sonpavde, Guru, Manitz, Juliane, Gao, Chen, Tayama, Darren, Kaiser, Constanze, Hennessy, Daniel, Makari, Doris, Gupta, Ashok, Abdullah, Shaad Essa, Niegisch, Guenter, Rosenberg, Jonathan E., Bajorin, Dean F., Grivas, Petros, Apolo, Andrea B., Dreicer, Robert, Hahn, Noah M., Galsky, Matthew D., Necchi, Andrea, Srinivas, Sandy, Powles, Thomas, Choueiri, Toni K., Pond, Gregory R.
Format: Artigo
Langue:Inglês
Publié: 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7655635/
https://ncbi.nlm.nih.gov/pubmed/32552295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JU.0000000000001199
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires